Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-002880-82Phase 4Unknown
Phase 4, randomised trial in gestational diabetes mellitus (GDM) comparing Ursofalk arm with Metformin arm (2 arms). Primary endpoint: Maternal fasting glucose concentration. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-002880-82.